Injeq’s IQ-Tip® needle receives CE certification – the Finnish innovation is ready for sales to the European market
Injeq Oy Press releaseJanuary 4, 2022 at 7:00 a.m. EET The medical technology company Injeq’s development yielded the desired outcome after many years of efforts as the company’s IQ-Tip® needle received CE approval on December 21, 2021. The needle can be used in lumbar punctures from newborns to the elderly, treatment punctures of children with leukemia being one of the main indications. For medical devices, the CE certification translates to a marketing authorization in Europe. In other words, the company can expect a new era of growth as a result of the certification.